CEL-SCI CORPORATION Revenue
CEL-SCI CORPORATION (CVM) reported Revenue of $51.82 thousand for the 9-month period ending 2017-06-30, per its 10-Q/A filed 2017-12-11.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2017-12-11
- CEL-SCI CORPORATION revenues for the quarter ending 2017-06-30 was $17.39K, a 86.62% decline year-over-year.
- CEL-SCI CORPORATION revenues for the quarter ending 2016-06-30 was $129.97K.
- CEL-SCI CORPORATION revenues for the quarter ending 2014-09-30 was $67.82K, a 338.95% increase year-over-year.
- CEL-SCI CORPORATION revenues for the quarter ending 2014-06-30 was $15.91K, a 86.01% decline year-over-year.
- CEL-SCI CORPORATION revenues for fiscal 2014 was $264.03K, a 65.45% increase from fiscal 2013.
- CEL-SCI CORPORATION revenues for fiscal 2013 was $159.58K, a 37.32% decline from fiscal 2012.
- CEL-SCI CORPORATION revenues for fiscal 2012 was $254.61K, a 73.37% decline from fiscal 2011.
- CEL-SCI CORPORATION revenues for fiscal 2011 was $956.15K.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2017-06-30 | $17.39K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | $51.82K 10-Q/A · filed 2017-12-11 | ||
| 2017-03-31 | $34.43K 10-Q/A · filed 2017-12-11 | |||
| 2016-06-30 | $129.97K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | $183.73K 10-Q/A · filed 2017-12-11 | ||
| 2016-03-31 | $53.75K 10-Q/A · filed 2017-12-11 | |||
| 2014-09-30 | $67.82K 10-K · filed 2014-12-23 | $83.73K derived: sum of 2 quarters · filed 2014-12-23 | $150.89K derived: sum of 3 quarters · filed 2014-12-23 | $264.03K 10-K · filed 2014-12-23 |
| 2014-06-30 | $15.91K 10-K · filed 2014-12-23 | $83.07K derived: sum of 2 quarters · filed 2014-12-23 | $196.22K derived: sum of 3 quarters · filed 2014-12-23 | $211.66K derived: sum of 4 quarters · filed 2014-12-23 |
| 2014-03-31 | $67.16K 10-K · filed 2014-12-23 | $180.30K derived: sum of 2 quarters · filed 2014-12-23 | $195.75K derived: sum of 3 quarters · filed 2014-12-23 | $309.48K derived: sum of 4 quarters · filed 2014-12-23 |
| 2013-12-31 | $113.14K 10-K · filed 2014-12-23 | $128.59K derived: sum of 2 quarters · filed 2014-12-23 | $242.32K derived: sum of 3 quarters · filed 2014-12-23 | $257.73K derived: sum of 4 quarters · filed 2014-12-23 |
| 2013-09-30 | $15.45K 10-K · filed 2014-12-23 | $129.18K derived: sum of 2 quarters · filed 2014-12-23 | $144.58K derived: sum of 3 quarters · filed 2014-12-23 | $159.58K 10-K · filed 2014-12-23 |
| 2013-06-30 | $113.73K 10-K · filed 2014-12-23 | $129.13K derived: sum of 2 quarters · filed 2014-12-23 | $144.13K derived: sum of 3 quarters · filed 2014-12-23 | $252.18K derived: sum of 4 quarters · filed 2014-12-23 |
| 2013-03-31 | $15.40K 10-K · filed 2014-12-23 | $30.41K derived: sum of 2 quarters · filed 2014-12-23 | $138.45K derived: sum of 3 quarters · filed 2014-12-23 | $173.45K derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-12-31 | $15.00K 10-K · filed 2014-12-23 | $123.04K derived: sum of 2 quarters · filed 2014-12-23 | $158.04K derived: sum of 3 quarters · filed 2014-12-23 | $264.59K derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-09-30 | $108.04K 10-K · filed 2013-12-27 | $143.04K derived: sum of 2 quarters · filed 2013-12-27 | $249.59K derived: sum of 3 quarters · filed 2013-12-27 | $254.61K 10-K · filed 2013-12-27 |
| 2012-06-30 | $35.00K 10-K · filed 2013-12-27 | $141.54K derived: sum of 2 quarters · filed 2013-12-27 | $146.57K derived: sum of 3 quarters · filed 2013-12-27 | $318.69K derived: sum of 4 quarters · filed 2013-12-27 |
| 2012-03-31 | $106.54K 10-K · filed 2013-12-27 | $111.57K derived: sum of 2 quarters · filed 2013-12-27 | $283.69K derived: sum of 3 quarters · filed 2013-12-27 | $361.09K derived: sum of 4 quarters · filed 2013-12-27 |
| 2011-12-31 | $5.02K 10-K · filed 2013-12-27 | $177.14K derived: sum of 2 quarters · filed 2013-12-27 | $254.54K derived: sum of 3 quarters · filed 2013-12-27 | $298.36K derived: sum of 4 quarters · filed 2013-12-27 |
| 2011-09-30 | $172.12K 10-K · filed 2012-12-14 | $249.52K derived: sum of 2 quarters · filed 2012-12-14 | $293.34K derived: sum of 3 quarters · filed 2012-12-14 | $956.15K 10-K · filed 2012-12-14 |
| 2011-06-30 | $77.40K 10-K · filed 2012-12-14 | $121.22K derived: sum of 2 quarters · filed 2012-12-14 | $784.04K 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $43.81K 10-K · filed 2012-12-14 | $706.63K derived: sum of 2 quarters · filed 2012-12-14 | ||
| 2010-12-31 | $662.82K 10-K · filed 2012-12-14 | |||
| 2010-06-30 | $30.90K 10-Q · filed 2011-08-09 | $91.50K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |